On Thursday, Synergy Pharmaceuticals Inc (NASDAQ:SGYP)’s shares declined -4.58% to $8.12.
Synergy Pharmaceuticals Inc. (SGYP) declared that its Chairman and Chief Executive Officer, Gary S. Jacob, Ph.D., will present a corporate update at the Canaccord Genuity 35th Annual Growth Conference on Thursday, August 13th, 2015 at 11:30 a.m. Eastern Time at the InterContinental in Boston, Massachusetts.
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders.
Callon Petroleum Company (NYSE:CPE)’s shares gained 17.95% to $7.49.
Callon Petroleum Company (CPE) stated results of operations for the three and six month periods ended June 30, 2015. Presentation slides accompanying this earnings release are accessible on the Company’s website at www.callon.com located within the Investors (Events and Presentations) section of the site.
Key highlights for the second quarter of 2015 comprise:
- Net daily production of 9,516 barrels of oil equivalent per day (“BOE/d”), an enhance of 11% contrast to the first quarter of 2015, comprised of 79% oil volume.
- Lease operating costs, counting workovers, of $7.59 per barrel of oil equivalent (“BOE”), a decrease of 16% contrast to the first quarter of 2015.
- Adjusted EBITDA, a non-GAAP financial measure(i), of $31.7 million, an enhance of 14% contrast to the first quarter of 2015.
- Adjusted income accessible to common shareholders, a non-GAAP financial measure(i), of $0.04 per diluted share based on total average diluted shares outstanding of 66.0 million shares.
Callon Petroleum Company engages in the exploration, development, acquisition, and production of oil and natural gas properties in the Permian Basin in West Texas. As of December 31, 2014, its estimated net proved reserves totaled 32.8 million barrel of oil equivalent, counting 25.7 million barrels of oil and 42.5 billion cubic feet of natural gas.
At the end of Thursday’s trade, Archer Daniels Midland Company (NYSE:ADM)‘s shares dipped -0.56% to $47.95.
Archer Daniels Midland Company’s (ADM) Board of Directors has declared a cash dividend of 28.0 cents per share on the company’s common stock payable Sept. 9, 2015, to Stockholders of record Aug. 19, 2015.
This is ADM’s 335th successive quarterly payment, a record of 83 years of uninterrupted dividends. As of June 30, 2015, there were 613,707,010 shares of ADM common stock outstanding.
Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities and products. The company’s Oilseeds Processing segment originates, merchandises, crushes, and processes soybeans and soft seeds into vegetable oils and protein meals. It offers ingredients for the food, feed, energy, and industrial products industries; crude vegetable and salad oils; refined oils; oilseed protein meals; natural health and nutrition products, and other specialty food and feed ingredients; and cottonseed flour and cotton cellulose pulp.
BorgWarner Inc. (NYSE:BWA), ended its Thursday’s trading session with -0.17% loss, and closed at $47.68.
BorgWarner produces S-Series turbochargers for Mercedes-Benz Actros heavy-duty trucks powered by its new engine, now produced in Brazil. BorgWarner supports the company with localized manufacturing for its entire Euro V engine line, producing turbochargers at its facility in Itatiba City, Brazil. BorgWarner received a 2014 Mercedes-Benz Brazil Supplier Award in the Innovation Technology category for its successful turbocharger launch for the new Mercedes-Benz Euro V engine families in South America.
For modern commercial vehicle applications, turbocharger life often depends on the durability of the compressor impeller. For greater reliability even under compriseently extreme loads, BorgWarner’s S-series turbochargers feature forged and milled titanium impellers, which resist low cycle fatigue (LCF) and high cycle fatigue (HCF) better than aluminum alloys. Dual-flow turbine housings divide exhaust gas flow to better utilize pulse energy to drive the turbine wheel, obtaining more power from the exhaust for dynamic response and high efficiency.
BorgWarner Inc. manufactures and sells engineered automotive systems and components primarily for powertrain applications worldwide. The company’s Engine segment offers turbochargers, timing devices and chain products, emissions systems, thermal systems, and diesel coldstart and gasoline ignition technology.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
